Flatiron Real-World Data
High-quality, global oncology data reflecting real-world care delivery
Platform · Cloud SaaSCompany source
Company profile
About Flatiron Health
Flatiron Health is an oncology-focused health technology company that organizes the world's real-world cancer data to accelerate research and improve patient care.
Company description Flatiron Health official website
Primary marketGenerative AI & Healthcare Infrastructure
Commercial modelCommercial information available on request
Work at Flatiron Health?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- cancer
- gastric cancer
- GEJ cancer
- HR+/HER2- metastatic breast cancer
- oncology
- prostate cancer
- urothelial cell carcinoma
Who it serves
- Community Oncologists
- Health Systems
- Life Sciences
- Pharma
- Providers
Deployment & integration
Cloud Saas deployment with recorded integration context.
Recorded integration context: Abbott Precision Oncology portfolio, OncoEMR.
Geographic context
MarketsGermany · Japan · United Kingdom · United States
Company sourceOfficial website
Company milestones
Platform expansion
Launched Flatiron Telescope AI platform, 49+ research acceptances at ASCO 2026, partnership with Community Oncology Alliance for comprehensive real-world assessment, Abbott integration with OncoEMR platform, 18 research acceptances at ISPOR 2026
Partnerships
Recorded partners
- Abbott
- Community Oncology Alliance
- Roche Group
- TailorMed
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
Flatiron Real-World Evidence Insights
Advanced analytics and expertise for actionable oncology insights
Platform · Cloud SaaSCompany source
Flatiron Telescope
AI-powered platform delivering oncology insights in minutes using natural language
Platform · Cloud SaaSCompany source
OncoEMR
Point of care EHR platform for community oncology practices
Software · Cloud SaaSCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
A scoping review of real-world data sources for retrospective oncology analysis in Japan.ESMO real world data and digital oncology · Sep 1, 2026
Recommendations for generating real-world evidence with regulatory-grade relevance and reliability.International journal of clinical oncology · Aug 20, 2026
Beyond the clinical trial: Real-world treatment patterns and drivers of PD-(L)1 therapy use in first-line metastatic NSCLC.Cancer treatment and research communications · Aug 6, 2026
Real-world clinical outcomes in patients with CLL previously treated with covalent BTKi and BCL2i regimens.Blood neoplasia · Aug 1, 2026
US real-world biomarker testing differences and treatment choice in advanced ovarian cancer: results of a retrospective study.Future oncology (London, England) · Jul 16, 2026
Using Regression Discontinuity in Time to Strengthen Real-World Evidence: A Case Study in Lung Cancer.Medical decision making : an international journal of the Society for Medical Decision Making · Jul 1, 2026
Clinical validation
Clinical-trial records
A Real-world Study of the First Treatment and Outcomes of Patients With Advanced or Metastatic Bladder CancerNCT07386847 · Mentioned · COMPLETED
Real World-clinical Outcomes of Tucatinib, Trastuzumab, and Capecitabine Following Trastuzumab Deruxtecan (T-DXd) for the Treatment of HER2-positive Metastatic Breast Cancer.NCT06961331 · Mentioned · COMPLETED
A Study to Learn About Two Medicines (Apalutamide and Enzalutamide) in People With Metastatic Castration-sensitive Prostate Cancer (mCSPC)NCT07086651 · Mentioned · COMPLETED
Real-World Outcomes of Patients With Metastatic Breast Cancer After Treatment With First-Line ET+CDK4/6iNCT06975371 · Mentioned · COMPLETED
A Study of Real-world Outcomes Among Patients Treated With RibociclibNCT07148505 · Mentioned · COMPLETED
Real-world Outcomes of Patients With HER2+ Metastatic Breast Cancer After Treatment With Trastuzumab DeruxtecanNCT06833268 · Mentioned · COMPLETED
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
5M+ patient records
Global oncology dataset
2,000+ peer-reviewed publications
Research impact powered by Flatiron data
45+ global regulatory decisions
Regulatory submissions informed
100% of top 20 oncology life sciences companies
Partner with Flatiron
Abbott
Expand access to Precision Oncology portfolio through OncoEMR integration
Expanded access to Precision Oncology portfolio
Community Oncology Alliance
Deliver first comprehensive, real-world assessment of care in community oncology
First comprehensive real-world assessment of community oncology care
TailorMed
Expand medication access and support across oncology care through partnership
Expanded medication access and support capabilities
Top 20 oncology life sciences companies
Drug development lifecycle support across clinical development, HEOR, market access, regulatory, and commercial functions
100% of the top 20 oncology life sciences companies partner with Flatiron
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
Rahul Bafna
Vice President of Product Management - Clinical Research
Quincy Weatherspoon
Vice President & GM, Flatiron Point of Care Solutions
Toni Ann Dearborn
Vice President of Product Management
Elcio Salgado
Vice President, Global Head of Talent Acquisition
Julia Morton
Chief Operating Officer
Rory Brecker
General Counsel
Andrew Shinohara
VP of Engineering, Platform
Cynthia Gillespie
Senior Clinical Abstraction Manager
06 · Company updates
Updates from Flatiron Health
Recent articles published on Flatiron Health's official website.
No Company updates are currently listed.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Generative AI & Healthcare Infrastructure
Companies providing generative AI platforms, large language models (LLMs), foundation models, or broad AI infrastructure specifically designed for healthcare applications. These companies serve multiple clinical use cases across the health system rather than focusing on a single clinical application or disease area.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.